Organon & Co.
OGN
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzysā¦ read more
Healthcare
Drug ManufacturersāGeneral
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.31
Price-0.15%
-$0.02
1Y
Price
Market Cap
$3.495b
Mid
Price/Earnings 3y Avg5y Avg
14.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+24.0%
EBITDA Margin+10.0%
Net Profit Margin+12.9%
Free Cash Flow Margin+24.0%
EBITDA Margin+10.0%
Net Profit Margin+12.9%
Free Cash Flow MarginRevenue
$6.163b
-0.9%
1y CAGR-0.5%
3y CAGR+0.0%
5y CAGREarnings
$246m
+31.6%
1y CAGR-20.8%
3y CAGR-12.7%
5y CAGREPS
$0.93
+29.2%
1y CAGR-21.9%
3y CAGR-13.6%
5y CAGRBook Value
$903k
$12.996m
Assets$12.093m
Liabilities$8.569m
DebtDebt to Assets
65.9%
-
Debt to EBITDAFree Cash Flow
$614m
+14.1%
1y CAGR+5.0%
3y CAGR+9.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company